5 Questions With Desmond Grimes, Business Development and Account Manager, InfoPathways, and BioHealth Capital Region Board of Buzz December 28, 2023 Based in Winston-Salem, North Carolina, Desmond has roots in [….]
As RTP continues to solidify its position as a top hub for contract manufacturing organizations, the industry is making the pathway to biomanufacturing employment even easier by offering high school students in two counties the opportunity to earn a BioWork certificate. Additionally, Novo Nordisk, a sponsor of the BioWork expansion, could be making its expansion with an addition to the company’s facility in Durham.
A Research Triangle Park firm is taking charge in the fight against fentanyl addiction. Cessation Therapeutics received a $14.8 million grant to support the development of its anti-fentanyl monoclonal antibody, CSX-1004. G1 Therapeutics’ Cosela won additional support as a myeloid supportive agent in the treatment of small-cell lung cancer. New research coming from Duke University could reshape the treatment landscape for multiple sclerosis.
Several new services and products developed in the RTP area are hitting the market, including a diagnostic test for Alzheimer’s developed by LabCorp, as well as Metabalon’s Liver Fibrosis and Kidney Function Discovery Panels. Merakris Therapeutics also unveiled its new personalized autologous serum tears that can be delivered to a patient’s front door. Area scientists also advanced research into peanut allergies and triple-negative breast cancer.
NCBio is undergoing a rebranding to NCLifeSci, which will reflect the expansion of the state’s ecosystem. Students and alumni from Wake Tech and Durham Tech participated in a massive life sciences jobs fair in Raleigh. Several RTP companies prepare for presentations at CHEST in Hawaii and Syneos Health announced a new CEO.
Corporate Executives are Driving Change and Focusing Their Teams on Patients
RTP will see a first-of-its-kind life sciences campus with HUB RTP. The new site will include offices, lab space, retail sites and even residential units. Pfizer will re-open its manufacturing facility in Rock Mount that was damaged by a tornado earlier this year. This will restore the flow of essential medicines used by hospitals across the country.
Ukrainian surgeons operating in the theater of war treated multiple patients with Humacyte’s experimental Human Acellular Vessel (HAV) device and saw highly significant results in the restoration of blood flow in patients, which led to reduced need for amputations. Data also showed low rates of infection in patients. The data will support a planned BLA later this year.
Two biopharma companies with deep ties to North Carolina saw setbacks this week. Nighthawk Biosciences announced plans to scale back operations and lay off 14% of its employees and a Novo Nordisk manufacturing facility in the state was flagged by the FDA for quality control issues. On the research front, researchers at N.C. State and UNC made strides on environmental and neurological fronts.
5 Questions With Angela Stoyanovitch, B.A., LATG, Founding Partner & Podcast Host, Legal Drugs Agency and Director of Business Development, USA, for Metrion Biosciences
